get a key
steadybase-$ company AVXL
account_id none on file
legal_name Anavex Life Sciences Corp.
ticker AVXL
cik 1314052
domain anavex.com
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
hq New York, NY, United States
calls 0 filings 2 executives 4 family 0
why_nownone on file
callsnone on file
filings
In addition to our talented internal team, we are actively building our leadership team with experienced leaders with a relevant clinical trial and regulatory experience to support our goals. | Target

company_statement / Sep 15, 2026 / receipt

We have paused development on these indications, and given our cash at hand and to be fiscally responsible, we have decided to focus our resources on the programs that we believe have the greatest pot

company_statement / Sep 15, 2026 / receipt

executives
Cameron Durrant director - receipt
Harvey Lalach director - receipt
Sandra Boenisch Principal Financial Officer - receipt
Terrie Kellmeyer Interim Chief Executive Officer - receipt
familynone on file
upcoming
2026-11-24 earnings call scheduled ir
changes
2026-05-06 Interim Chief Executive Officer, appointed sec_8k
2015-10-07 Principal Financial Officer, appointed sec_8k
2015-10-06 Principal Financial Officer, appointed sec_8k
2013-01-10 director, departed sec_8k
2011-10-21 director, departed sec_8k
2011-04-18 director, appointed sec_8k
2010-05-04 director, appointed sec_8k
mcp_package_hint
steadybase-$